Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New laser shows promise for wrinkle reduction in clinical trial

NCT ID NCT07572331

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a laser device (NIRA Laser M2.1) on 120 adults aged 35 and older to see if it could safely reduce full-face wrinkles. Some participants also used a topical cream after the laser. Wrinkle improvement was judged by experts looking at before-and-after photos, and participants reported their satisfaction. The goal was to ease the appearance of wrinkles, not to cure a disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Jan 2025

Finished

Oct 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant is aged 35 years or older * Possesses valid photo ID * Willing to comply with all study requirements * Willing to take the device home for daily treatments * Willing to wear sunscreen when exposed to the sun * Willing to avoid wrinkle creams, microneedling, Botox, fillers, and similar cosmetic procedures during study participation * Willing to come to the office every four weeks for evaluation * Willing to be photographed and sign Information Release Consent * Willing to provide informed consent to participate * Fitzpatrick Skin Type grading I to VI * Fitzpatrick Wrinkle Scale grading of 4 or higher on a scale of 1 to 9 * Owns and regularly uses at least one email account * Willing to synchronize the NIRA device with the sponsor server monthly * Willing to log in to the sponsor web portal monthly to view usage history * Willing to read sponsor emails for feedback on study compliance * For female participants of childbearing potential: willing to use an acceptable form of birth control throughout the study, with consistent use for at least 30 days before study participation, and negative urine pregnancy test at baseline Exclusion Criteria: * Participant is pregnant, planning to be pregnant, undergoing fertility treatments, or nursing * Laser treatments on the face within the last 4 weeks * Severely immunocompromised state, such as AIDS, renal transplant regimens, immunosuppressed states consequent to malignancy or agents used in oncologic care, or end-stage renal disease * Psoriasis or lichen planus on the face * Microneedling, radiofrequency, fillers, or Botox treatments within study treatment areas in the past 3 months * If topical wrinkle agents such as tretinoin were used, participant must complete a 4-week washout period before starting the study protocol and be rescreened accordingly * Incapable adults who require enrollment by consent of a legally authorized representative

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acne are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris porphyria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Northeast Dermatology Associates

    Beverly, Massachusetts, 01915, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.